US Stock
Closed Market
Alnylam Pharmaceuticals Stock
•ALNYClosed Market
$318,91
+$5,50(1,75%)Past Day
$0(0,00%)After Hours
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 2,500 full-time employees. The company went IPO on 2004-05-28. The firm is engage Read moreSectorHealth Care
IndustryPharmaceuticals, Biotechnology & Life Sciences
ExchangeNASDAQ NMS - GLOBAL MARKET
Employees2,500
HeadquarterCambridge, United States
Websitealnylam.com
SymbolALNY
Key Statistics
General
Valuation Ratios
Profitability
Market Cap0
Dividend Yield$0
Avg. Volume0
Earnings per Share$0
Enterprise Value (EV)$0
52w High$0 (Invalid Date)
52w Low$0 (Invalid Date)
1Y Drawdown0%
EBITDA$0
PEG Ratio0,00
People Also Bought
AAL$10,92
+4,08%
LYFT$14,09
+3,99%
UBER$77,61
+3,94%
DAL$63,84
+4,95%
UAL$94,30
+4,45%
LUV$41,38
+2,86%
CG$48,54
+4,66%
ED$118,87
+2,88%
LMND$62,15
+7,51%
ENTG$111,64
+3,10%
SAVA$2,38
+12,26%
AMPL$7,60
+4,41%
BMO$139,78
+3,12%
E$53,36
+3,45%
QVCGA$3,15
+5,88%
AAL$10,92
+4,08%
LYFT$14,09
+3,99%
UBER$77,61
+3,94%
DAL$63,84
+4,95%
UAL$94,30
+4,45%
LUV$41,38
+2,86%
CG$48,54
+4,66%
ED$118,87
+2,88%
LMND$62,15
+7,51%
ENTG$111,64
+3,10%
SAVA$2,38
+12,26%
AMPL$7,60
+4,41%
BMO$139,78
+3,12%
E$53,36
+3,45%
QVCGA$3,15
+5,88%
